Clinical Trial Update: Inspiratory Flow Using the Osmohaler

View source ↗

Summary

This completed clinical trial (NCT00531414) sponsored by Syntara evaluated inspiratory flow using the Osmohaler in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Syntara | Conditions: Asthma | Status: COMPLETED